An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin

The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplatin, platinum was distributed throughout the kidney even up to 14 days after treatment. In t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 1988-01, Vol.22 (3), p.241-245
Hauptverfasser: EWEN, C, PERERA, A, HENDRY, J. H, MCAULIFFE, C. A, SHARMA, H, FOX, B. W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 245
container_issue 3
container_start_page 241
container_title Cancer chemotherapy and pharmacology
container_volume 22
creator EWEN, C
PERERA, A
HENDRY, J. H
MCAULIFFE, C. A
SHARMA, H
FOX, B. W
description The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplatin, platinum was distributed throughout the kidney even up to 14 days after treatment. In the case of iproplatin and paraplatin rapid platinum clearance was noted from the glomeruli, blood vessels and renal medulla within 2 h of administration. Relative cortical and medullary platinum radionuclide concentrations for all three agents were determined by Chalkley grid analysis. This showed greater relative concentrations of platinum in the cortex at increasing times following iproplatin and paraplatin compared with cisplatin. It is suggested that the lower renal toxicity of iproplatin and paraplatin than of cisplatin may be due to reduced platinum retention within the pars recta.
doi_str_mv 10.1007/BF00273418
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00273418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3044632</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-e7c9328cc36f89736fa20942efc259b3a95a624d7771924cdb7a3a6e688244fa3</originalsourceid><addsrcrecordid>eNpFkD1PwzAQhi0EKqWwsCN5YEIE_HGN4xEqCkiVWGCOro5NjVInstOh_x7TVmW5D73Pne5eQq45e-CMqcfnOWNCSeDVCRlzkKJgFchTMmYSoJgqBufkIqUfxhhwKUdkJBlAKcWYhKdAcTN0ERvffUfsV97QNGyaLe0cHVaW-jBEjDZgS9vOYOsTDr7LU6Gh0Q427LoMG5_6Nmvhnvo-dvt6h_WYF-_aS3LmsE326pAn5Gv-8jl7KxYfr--zp0VhJOdDYZXRUlTGyNJVWuWIgmkQ1hkx1UuJeoqlgEYpxbUA0ywVSixtWVUCwKGckLv9XhO7lKJ1dR_9GuO25qz-86z-9yzDN3u43yzXtjmiB5OyfnvQMWUDXMSQfz1ipdb5DJC_Hxp0rw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>EWEN, C ; PERERA, A ; HENDRY, J. H ; MCAULIFFE, C. A ; SHARMA, H ; FOX, B. W</creator><creatorcontrib>EWEN, C ; PERERA, A ; HENDRY, J. H ; MCAULIFFE, C. A ; SHARMA, H ; FOX, B. W</creatorcontrib><description>The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplatin, platinum was distributed throughout the kidney even up to 14 days after treatment. In the case of iproplatin and paraplatin rapid platinum clearance was noted from the glomeruli, blood vessels and renal medulla within 2 h of administration. Relative cortical and medullary platinum radionuclide concentrations for all three agents were determined by Chalkley grid analysis. This showed greater relative concentrations of platinum in the cortex at increasing times following iproplatin and paraplatin compared with cisplatin. It is suggested that the lower renal toxicity of iproplatin and paraplatin than of cisplatin may be due to reduced platinum retention within the pars recta.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/BF00273418</identifier><identifier>PMID: 3044632</identifier><identifier>CODEN: CCPHDZ</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Animals ; Antineoplastic agents ; Antineoplastic Agents - pharmacokinetics ; Autoradiography ; Biological and medical sciences ; Carboplatin ; Cisplatin - pharmacokinetics ; General aspects ; Isotope Labeling ; Kidney - metabolism ; Male ; Medical sciences ; Mice ; Organoplatinum Compounds - pharmacokinetics ; Pharmacology. Drug treatments ; Platinum ; Quality Control ; Radioisotopes</subject><ispartof>Cancer chemotherapy and pharmacology, 1988-01, Vol.22 (3), p.241-245</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-e7c9328cc36f89736fa20942efc259b3a95a624d7771924cdb7a3a6e688244fa3</citedby><cites>FETCH-LOGICAL-c311t-e7c9328cc36f89736fa20942efc259b3a95a624d7771924cdb7a3a6e688244fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=6997714$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3044632$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EWEN, C</creatorcontrib><creatorcontrib>PERERA, A</creatorcontrib><creatorcontrib>HENDRY, J. H</creatorcontrib><creatorcontrib>MCAULIFFE, C. A</creatorcontrib><creatorcontrib>SHARMA, H</creatorcontrib><creatorcontrib>FOX, B. W</creatorcontrib><title>An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin</title><title>Cancer chemotherapy and pharmacology</title><addtitle>Cancer Chemother Pharmacol</addtitle><description>The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplatin, platinum was distributed throughout the kidney even up to 14 days after treatment. In the case of iproplatin and paraplatin rapid platinum clearance was noted from the glomeruli, blood vessels and renal medulla within 2 h of administration. Relative cortical and medullary platinum radionuclide concentrations for all three agents were determined by Chalkley grid analysis. This showed greater relative concentrations of platinum in the cortex at increasing times following iproplatin and paraplatin compared with cisplatin. It is suggested that the lower renal toxicity of iproplatin and paraplatin than of cisplatin may be due to reduced platinum retention within the pars recta.</description><subject>Animals</subject><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - pharmacokinetics</subject><subject>Autoradiography</subject><subject>Biological and medical sciences</subject><subject>Carboplatin</subject><subject>Cisplatin - pharmacokinetics</subject><subject>General aspects</subject><subject>Isotope Labeling</subject><subject>Kidney - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Organoplatinum Compounds - pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Platinum</subject><subject>Quality Control</subject><subject>Radioisotopes</subject><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkD1PwzAQhi0EKqWwsCN5YEIE_HGN4xEqCkiVWGCOro5NjVInstOh_x7TVmW5D73Pne5eQq45e-CMqcfnOWNCSeDVCRlzkKJgFchTMmYSoJgqBufkIqUfxhhwKUdkJBlAKcWYhKdAcTN0ERvffUfsV97QNGyaLe0cHVaW-jBEjDZgS9vOYOsTDr7LU6Gh0Q427LoMG5_6Nmvhnvo-dvt6h_WYF-_aS3LmsE326pAn5Gv-8jl7KxYfr--zp0VhJOdDYZXRUlTGyNJVWuWIgmkQ1hkx1UuJeoqlgEYpxbUA0ywVSixtWVUCwKGckLv9XhO7lKJ1dR_9GuO25qz-86z-9yzDN3u43yzXtjmiB5OyfnvQMWUDXMSQfz1ipdb5DJC_Hxp0rw</recordid><startdate>19880101</startdate><enddate>19880101</enddate><creator>EWEN, C</creator><creator>PERERA, A</creator><creator>HENDRY, J. H</creator><creator>MCAULIFFE, C. A</creator><creator>SHARMA, H</creator><creator>FOX, B. W</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19880101</creationdate><title>An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin</title><author>EWEN, C ; PERERA, A ; HENDRY, J. H ; MCAULIFFE, C. A ; SHARMA, H ; FOX, B. W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-e7c9328cc36f89736fa20942efc259b3a95a624d7771924cdb7a3a6e688244fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - pharmacokinetics</topic><topic>Autoradiography</topic><topic>Biological and medical sciences</topic><topic>Carboplatin</topic><topic>Cisplatin - pharmacokinetics</topic><topic>General aspects</topic><topic>Isotope Labeling</topic><topic>Kidney - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Organoplatinum Compounds - pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Platinum</topic><topic>Quality Control</topic><topic>Radioisotopes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EWEN, C</creatorcontrib><creatorcontrib>PERERA, A</creatorcontrib><creatorcontrib>HENDRY, J. H</creatorcontrib><creatorcontrib>MCAULIFFE, C. A</creatorcontrib><creatorcontrib>SHARMA, H</creatorcontrib><creatorcontrib>FOX, B. W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EWEN, C</au><au>PERERA, A</au><au>HENDRY, J. H</au><au>MCAULIFFE, C. A</au><au>SHARMA, H</au><au>FOX, B. W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><addtitle>Cancer Chemother Pharmacol</addtitle><date>1988-01-01</date><risdate>1988</risdate><volume>22</volume><issue>3</issue><spage>241</spage><epage>245</epage><pages>241-245</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><coden>CCPHDZ</coden><abstract>The intrarenal localisation of platinum following the intravenous administration of platinum-195m-labelled cisplatin, iproplatin and paraplatin was studied using autoradiography. Following injection of cisplatin, platinum was distributed throughout the kidney even up to 14 days after treatment. In the case of iproplatin and paraplatin rapid platinum clearance was noted from the glomeruli, blood vessels and renal medulla within 2 h of administration. Relative cortical and medullary platinum radionuclide concentrations for all three agents were determined by Chalkley grid analysis. This showed greater relative concentrations of platinum in the cortex at increasing times following iproplatin and paraplatin compared with cisplatin. It is suggested that the lower renal toxicity of iproplatin and paraplatin than of cisplatin may be due to reduced platinum retention within the pars recta.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>3044632</pmid><doi>10.1007/BF00273418</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 1988-01, Vol.22 (3), p.241-245
issn 0344-5704
1432-0843
language eng
recordid cdi_crossref_primary_10_1007_BF00273418
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Animals
Antineoplastic agents
Antineoplastic Agents - pharmacokinetics
Autoradiography
Biological and medical sciences
Carboplatin
Cisplatin - pharmacokinetics
General aspects
Isotope Labeling
Kidney - metabolism
Male
Medical sciences
Mice
Organoplatinum Compounds - pharmacokinetics
Pharmacology. Drug treatments
Platinum
Quality Control
Radioisotopes
title An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T08%3A10%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20autoradiographic%20study%20of%20the%20intrarenal%20localisation%20and%20retention%20of%20cisplatin,%20iproplatin%20and%20paraplatin&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=EWEN,%20C&rft.date=1988-01-01&rft.volume=22&rft.issue=3&rft.spage=241&rft.epage=245&rft.pages=241-245&rft.issn=0344-5704&rft.eissn=1432-0843&rft.coden=CCPHDZ&rft_id=info:doi/10.1007/BF00273418&rft_dat=%3Cpubmed_cross%3E3044632%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3044632&rfr_iscdi=true